Search Results 71-80 of 23353 for celiac disease

  1. A Study of Simvastatin Metabolism as a Test for Celiac Disease Activity - Mayo Clinic

    ... celiac disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  2. A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten Sensitivity - Mayo Clinic

    A Study of the Response to and Changes in Intestinal Permeability 4 hours after a Gluten Challenge in Subjects with Celiac Disease and Non Celiac Gluten ...

  3. VTP-1000 In Celiac Disease - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Gut Permeability Assessment in Celiac and Gluten Sensitive Children - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Blood Pressure Drug Creates Severe GI Problems And Symptoms Of Celiac Disease - Mayo Clinic News Network

    Blood Pressure Drug Creates Severe GI Problems And Symptoms Of Celiac Disease ... celiac disease. Lead author and Mayo Clinic gastroenterologist, Joseph ...

  6. Celiac disease / ductal carcinoma in situ / eating smart during the holidays: Mayo Clinic Radio

    On this Mayo Clinic Radio podcast, Dr. Joseph Murray, a Mayo Clinic gastroenterologist, will discuss diagnosing and treating celiac disease.

  7. Evaluation Of The Efficacy And Safety Of ALV003 In Symptomatic In Celiac Disease Patients - Mayo Clinic

    ... and symptoms in celiac disease patients. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  8. A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Latiglutenase To Treat Patients With Well-Controlled Celiac Disease - Mayo Clinic

    A Study To Evaluate The Safety, Effectiveness, And Tolerability Of Latiglutenase To Treat Patients With Well-Controlled Celiac Disease · Share · Facebook · Twitter.

  9. A Study of the Safety, Effectiveness and Tolerability of Nexvax-2 in Patients with Celiac Disease (CeD) - Mayo Clinic

    The purpose of this study is to evaluate the human leukocyte antigen (HLA)-DQ 2.5+ in adults with celiac disease (CeD). Participation eligibility. Participant ...

  10. A Phase 2a/b Study Of The Efficacy And Safety Of Subcutaneous Amlitelimab In Adults With Nonresponsive Celiac Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a ...